Application segmentation breaks the market into six primary clinical domains: General Surgery (35%), Gynecology (20%), Neurosurgery (15%), ENT (10%), Orthopedics (12%), and Cosmetic Surgery (8%). General surgery leads the share because ultrasonic electrosurgical units are integral to procedures such as laparoscopic cholecystectomy and colorectal resections, where rapid tissue transection and reliable hemostasis are essential. Gynecology follows, propelled by minimally invasive hysterectomy and myomectomy techniques that benefit from reduced collateral damage. Neurosurgery, though a smaller segment, commands premium pricing due to the need for precise, low‑thermal‑injury cutting in delicate neural tissue. ENT applications, including tonsillectomy and sinus surgery, leverage the technology’s ability to minimize postoperative edema. Orthopedic use is expanding as surgeons adopt ultrasonic tools for bone cutting and soft‑tissue management in joint reconstruction. Cosmetic surgery, while niche, contributes growth through demand for refined aesthetic outcomes with minimal scarring. These application shares collectively define the market taxonomy and guide manufacturers in tailoring device portfolios to procedure‑specific performance criteria.